Table 1 Clinical features before and after PSM.
Features | All patients | Propensity-matched patients | ||||
|---|---|---|---|---|---|---|
PI-Group (n = 456) | NI-Group (n = 456) | P | PI-Group (n = 277) | NI-Group (n = 277) | P | |
Age | 51.61 ± 8.529 | 60.41 ± 10.596 | < 0.001 | 55.08 ± 7.815 | 56 ± 9.305 | 0.125 |
Gender | 282 (61.8%) | 246 (53.9%) | 0.016 | 173 (62.5%) | 165 (59.6%) | 0.536 |
Smoker | 210 (46.1%) | 162 (35.5%) | 0.002 | 108 (39%) | 115 (41.5%) | 0.621 |
Hypertension | 156 (34.2%) | 126 (27.6%) | 0.032 | 85 (30.7%) | 74 (27.4%) | 0.439 |
Diabetes | 135 (29.6%) | 102 (22.4%) | 0.013 | 70 (25.3%) | 74 (26.7%) | 0.773 |
Drinking | 81 (17.8%) | 51 (11.2%) | 0.005 | 28 (10.1%) | 37 (13.4%) | 0.314 |
6-p-scale | 1.74 ± 0.816 | 1.82 ± 0.852 | 0.153 | 1.78 ± 0.849 | 1.69 ± 0.797 | 0.176 |
FMA | 3.48 ± 0.874 | 3.49 ± 0.836 | 0.816 | 3.49 ± 0.919 | 3.58 ± 0.751 | 0.238 |
Barthel | 78.72 ± 11.562 | 75.63 ± 12.662 | < 0.001 | 77.29 ± 11.479 | 78.48 ± 12.692 | 0.233 |
